S
Spyridon Deftereos
Researcher at National and Kapodistrian University of Athens
Publications - 219
Citations - 5467
Spyridon Deftereos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 30, co-authored 198 publications receiving 4023 citations. Previous affiliations of Spyridon Deftereos include Yale University & AHEPA University Hospital.
Papers
More filters
Journal ArticleDOI
2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia
Josep Brugada,Demosthenes G. Katritsis,Elena Arbelo,Fernando Arribas,Jeroen J. Bax,Carina Blomström-Lundqvist,Hugh Calkins,Domenico Corrado,Spyridon Deftereos,Gerhard-Paul Diller,Juan J Gomez-Doblas,Bulent Gorenek,Andrew A. Grace,Siew Yen Ho,Juan Carlos Kaski,Karl-Heinz Kuck,Pier D. Lambiase,Frederic Sacher,Georgia Sarquella-Brugada,Piotr Suwalski,Antonio Zaza +20 more
TL;DR: The ESC Guidelines for the management of patients with supraventricular tachycardia as discussed by the authors were developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC).
Journal ArticleDOI
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Spyridon Deftereos,Georgios Giannopoulos,Dimitrios A. Vrachatis,Gerasimos Siasos,Sotiria G. Giotaki,Panagiotis Gargalianos,Simeon Metallidis,George Sianos,Stefanos Baltagiannis,Periklis Panagopoulos,Konstantinos Dolianitis,Efthalia Randou,Konstantinos N. Syrigos,Anastasia Kotanidou,Nikolaos Koulouris,Haralampos J. Milionis,Nikolaos V. Sipsas,Charalampos Gogos,George Tsoukalas,Christoforos Olympios,Eleftheria P Tsagalou,Ilias Migdalis,Styliani Gerakari,Christos Angelidis,Dimitrios Alexopoulos,Pericles Davlouros,George Hahalis,Ioannis Kanonidis,Demosthenes G. Katritsis,Theofilos M. Kolettis,Antonios S. Manolis,Lampros K. Michalis,Katerina K. Naka,Vlasios Pyrgakis,Konstantinos Toutouzas,Filippos Triposkiadis,Konstantinos Tsioufis,Emmanouil Vavouranakis,Luis Martínez-Dolz,Bernhard Reimers,Giulio G. Stefanini,Michael W. Cleman,John A. Goudevenos,Sotirios Tsiodras,Dimitrios Tousoulis,Efstathios K. Iliodromitis,Roxana Mehran,George Dangas,Christodoulos Stefanadis,Christodoulos Stefanadis +49 more
TL;DR: A role for colchicine in the treatment of patients with coronavirus disease 2019 is suggested, with results suggesting a smaller increase in dimerized plasma fragment D compared with patients in the control group.
Journal ArticleDOI
Cardioprotective Role of Remote Ischemic Periconditioning in Primary Percutaneous Coronary Intervention: Enhancement by Opioid Action
Ilias Rentoukas,Georgios Giannopoulos,Andreas Kaoukis,Charalampos Kossyvakis,Konstantinos Raisakis,Metaxia Driva,Vasiliki Panagopoulou,Konstantinos Tsarouchas,Sofia Vavetsi,Vlasios Pyrgakis,Spyridon Deftereos +10 more
TL;DR: These findings demonstrate a cardioprotective effect of RIPC and morphine during primary percutaneous coronary intervention for the prevention of reperfusion injury.
Journal ArticleDOI
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.
Jean-Claude Tardif,Nadia Bouabdallaoui,Philippe L. L’Allier,Daniel Gaudet,Binita Shah,Michael H. Pillinger,Jose Lopez-Sendon,Protasio da Luz,Lucie Verret,Sylvia Audet,Jocelyn Dupuis,André Y. Denault,Martin Pelletier,Philippe A. Tessier,Sarah Samson,Denis Fortin,J.C. Tardif,David Busseuil,Elisabeth Goulet,Chantal Lacoste,Anick Dubois,Avni Y. Joshi,David D. Waters,Priscilla Y. Hsue,Norman E. Lepor,Frédéric Lesage,Nicolas Sainturet,Eve Roy-Clavel,Zohar Bassevitch,Andreas Orfanos,Gabriela Stamatescu,Jean Grégoire,Lambert Busque,Christian Lavallée,Pierre-Olivier Hétu,Jean-Sébastien Paquette,Spyridon Deftereos,Sylvie Levesque,Mariève Cossette,Anna Nozza,Malorie Chabot-Blanchet,Marie-Pierre Dubé,Marie-Claude Guertin,Guy Boivin +43 more
TL;DR: The COLCORONA trial as mentioned in this paper investigated the effect of colchicine on the composite of COVID-19-related death or hospital admission and found that colchics led to a lower rate of the composite adverse events than placebo.
Journal ArticleDOI
Colchicine for Prevention of Early Atrial Fibrillation Recurrence After Pulmonary Vein Isolation: A Randomized Controlled Study
Spyridon Deftereos,Georgios Giannopoulos,Charalambos Kossyvakis,Michael Efremidis,Vasiliki Panagopoulou,Andreas Kaoukis,Konstantinos Raisakis,Georgios Bouras,Christos Angelidis,Andreas Theodorakis,Metaxia Driva,Konstantinos Doudoumis,Vlasios Pyrgakis,Christodoulos Stefanadis +13 more
TL;DR: Colchicine is an effective and safe treatment for prevention of early AF recurrences after pulmonary vein isolation in the absence of antiarrhythmic drug treatment and seems to be associated strongly with a significant decrease in inflammatory mediators, including IL-6 and CRP.